Beijing Anzhen Hospital

Running trials

• Not yet recruiting

  Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients

  NCT07897305· Source

• Not yet recruiting

  Diagnostic Performance of an AI-Based Multi-Omics Model for Early Lung Cancer

  NCT07882628· Source

• Recruiting

  A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation

  NCT07845682· Source

• Recruiting

  A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China

  NCT07900438· Phase 4· Source

• Not yet recruiting

  A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) Therapy

  NCT07794397· Phase 3· Source

• Not yet recruiting

  Low-dose Colchicine for CABG Graft Failure Prevention

  NCT07569328· Source

• Not yet recruiting

  Prospective Study on the Effectiveness and Safety of Bi-polar Pulse-field Tip-catheter Ablation for Atrial Fibrillation in China（POTENTIAL-AF）

  NCT07627685· Source

• Recruiting

  A Personalized Mobile Application Providing Temperature-Related Health Risk Warnings and Protective Recommendations for Patients With Chronic Obstructive Pulmonary Disease

  NCT07656142· Source

• Not yet recruiting

  Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

  NCT07630454· Phase 4· Source

• Not yet recruiting

  The COMBINE-AF Trial

  NCT07633509· Source

• Not yet recruiting

  Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial

  NCT07678151· Source

• Recruiting

  Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly

  NCT07403760· Source

• Recruiting

  Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure

  NCT07704424· Source

• Recruiting

  Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation

  NCT07414225· Source

• Recruiting

  A Clinical Study of HRS-5765 in Healthy Participants

  NCT07551167· Phase 1· Source

• Recruiting

  Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension

  NCT07607275· Phase 4· Source

• Recruiting

  Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

  NCT07444372· Source

• Active, not recruiting

  Study of IBI3016 in People With Mild or Moderate Hypertension Patients

  NCT07556796· Phase 1· Source

• Recruiting

  SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)

  NCT07316270· Source

• Recruiting

  Grid eXplore Mapping Study

  NCT07421076· Source

• Active, not recruiting

  Safety and Efficacy of Conscious Sedation Versus General Anesthesia in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation

  NCT07541339· Source

• Not yet recruiting

  Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI

  NCT07511231· Source

• Recruiting

  Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF)

  NCT07352891· Source

• Active, not recruiting

  A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients

  NCT07352969· Phase 2· Source

• Active, not recruiting

  Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension

  NCT07297797· Phase 2· Source

• Recruiting

  Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY

  NCT07137936· Source

• Not yet recruiting

  Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)

  NCT07353762· Source

• Not yet recruiting

  The Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD)

  NCT07315399· Source

• Recruiting

  PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy

  NCT07443696· Phase 2· Source

• Recruiting

  A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

  NCT07654140· Phase 2· Source

• Not yet recruiting

  For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.

  NCT07264881· Source

• Recruiting

  Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)

  NCT07439133· Phase 3· Source

• Recruiting

  Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke

  NCT07290751· Phase 4· Source

• Recruiting

  Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

  NCT06855537· Phase 4· Source

• Not yet recruiting

  A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

  NCT07230145· Phase 1· Source

• Recruiting

  Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial

  NCT07648693· Source

• Recruiting

  Complex Arrhythmia Registry

  NCT07024927· Source

• Recruiting

  Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

  NCT06615596· Early phase 1· Source

• Recruiting

  Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation

  NCT06871228· Source

• Recruiting

  Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke

  NCT07026331· Source

• Recruiting

  Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease

  NCT07657624· Source

• Recruiting

  A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis

  NCT07034157· Source

• Recruiting

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· Phase 3· Source

• Recruiting

  Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis

  NCT06885619· Source

• Recruiting

  Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

  NCT06883864· Source

• Not yet recruiting

  Photoplethysmography (PPG) Algorithm with Smartwatch in Evaluation of Atrial Fibrillation Burden After Catheter Ablation

  NCT06842160· Source

• Recruiting

  Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)

  NCT06922240· Phase 3· Source

• Recruiting

  Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation

  NCT06842147· Source

• Recruiting

  Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients

  NCT06862700· Source

• Recruiting

  To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension

  NCT07051811· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation23 recruiting
• Coronary artery disease22 recruiting
• Heart failure15 recruiting
• High blood pressure8 recruiting
• Obesity5 recruiting
• Stroke4 recruiting
• Amyloidosis3 recruiting
• Pulmonary arterial hypertension2 recruiting
• Alzheimer disease1 recruiting
• Chronic kidney disease1 recruiting
• COPD1 recruiting
• Lung cancer1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Electrophysiologist-led Deep Sedation Protocols for Pulsed Field Ablation for Atrial Fibrillation Using a Bipolar Tip-Catheter: The DEEP-PFA Randomized Controlled Trial

  NCT07149545· Source

• Completed

  Safety, Tolerability and Pharmacokinetic Study of HRS-8829

  NCT07083362· Phase 1· Source

• Completed

  A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

  NCT07091929· Phase 1· Source

• Withdrawn

  Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease

  NCT06598631· Phase 2· Source

• Completed

  A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects

  NCT07079618· Phase 1· Source

• Completed

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· Phase 2· Source

• Completed

  Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation

  NCT06433479· Source

• Completed

  An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

  NCT06421740· Source

• Completed

  Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

  NCT06354556· Phase 1· Source

• Completed

  A Study on the Effectiveness of the Application of an Artificial Intelligence Algorithm for Calibrating PPG With ECG to Improve the Accuracy of Atrial Fibrillation Burden Estimation

  NCT06552468· Source

• Completed

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Source

• Completed

  An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

  NCT06116968· Phase 3· Source

• Completed

  YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

  NCT06048588· Phase 1/2· Source

• Completed

  InsightPFA Trial of the LotosPFA Catheter

  NCT06014996· Source

• Completed

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

  NCT05952856· Phase 3· Source

• Completed

  A Prospective, Multicenter, Blinded, Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of IVUS Console and IVUS Catheter in Coronary Intervention Procedures

  NCT06974760· Source

• Completed

  AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia

  NCT07030595· Phase 3· Source

• Completed

  A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy

  NCT05879523· Phase 1· Source

• Completed

  Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

  NCT05949801· Phase 3· Source

• Completed

  A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）

  NCT06691477· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Source

• Completed

  Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

  NCT05593575· Phase 2· Source

• Completed

  TESTING -ON Post-Trial ObservatioNal Cohort Study

  NCT05434325· Source

• Completed

  Atrial Fibrillation Follow-up Investigation to Recover Memory and learnING Trial

  NCT05374642· Source

• Completed

  Outcomes of a Novel Magnetically Levitated LVAD: a Multicenter Analysis

  NCT06596499· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· Phase 3· Source

• Completed

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· Phase 3· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Source

• Completed

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· Phase 3· Source

• Completed

  Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation

  NCT04497376· Source

• Completed

  Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

  NCT05359068· Phase 3· Source

• Completed

  Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

  NCT04747496· Source

• Completed

  Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block (LEAP-Block)

  NCT04730921· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Source

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Source

• Completed

  EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

  NCT03950076· Phase 4· Source

• Completed

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· Phase 3· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Source

Trial sites

• Beijing Anzhen Hospital45 trials
• Beijing Anzhen Hospital, Capital Medical University63 trials
• Beijing Anzhen Hospital, Capital Medical University-12 Ward1 trial
• Beijing Anzhen Hospital, Capital Medical University-28 Ward1 trial
• Beijing Anzhen Hospital, Capital Medical University-33 Ward1 trial
• Beijing Anzhen Hospital, Capital Medical University, Beijing, China2 trials
• Beijing Anzhen Hospital, Capital Medical University-Cardiovascular (Site 0856)1 trial
• Beijing Anzhen Hospital, Capital Medical University-Cardiovascular (Site 3300)1 trial
• Beijing Anzhen Hospital, Capital Medical University-Cardiovascular (Site 3400)1 trial
• Beijing Anzhen Hospital, Capital Medical University-Cardiovascular (Site 6000)1 trial
• Beijing Anzhen Hospital, Capital Medical University-Nephrology1 trial
• Beijing Anzhen Hospital /ID# 2734431 trial
• Capital Medical University (CMU) - Beijing Anzhen Hospital (BAH)1 trial
• Capital Medical University (CMU) - Beijing Anzhen Hospital (BAH) - Site #361 trial
• Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University1 trial
• Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.1 trial
• Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital2 trials
• Beijing Anzhen Hospital1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke176 works · 8 trials
• Heart failure169 works · 23 trials
• Atrial fibrillation108 works · 33 trials
• Coronary artery disease95 works · 28 trials
• Hypertrophic cardiomyopathy27 works · 4 trials
• Pulmonary arterial hypertension12 works · 7 trials
• High blood pressure7 works · 17 trials
• Familial hypercholesterolaemia6 works · 2 trials